Location of Repository

Lack of Evidence for Changing Virulence of HIV-1 in North America

By Joshua T. Herbeck, Geoffrey S. Gottlieb, Xiuhong Li, Zheng Hu, Roger Detels, John Phair, Charles Rinaldo, Lisa P. Jacobson, Joseph B. Margolick and James I. Mullins
Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2211407
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. Arts EJ (2007) Is HIV-1 evolving to a less virulent form in humans?
    2. (1999). Association between the Rate of
    3. (1998). Biological and virologic characteristics of primary HIV infection.
    4. (2004). Brief but Efficient: Acute HIV Infection and the Sexual Transmission of HIV.
    5. (2007). CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms.
    6. (2005). Changes over time in postseroconversion CD4 cell counts in the Italian HIV-Seroconversion Study:
    7. (2003). Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion.
    8. (2007). Estimating the Benefit of an HIV-1 Vaccine That Reduces Viral Load Set Point.
    9. (1995). Evaluation of secular trends in CD4+ lymphocyte loss among human immunodeficiency HIV-1 Virulence Stable in
    10. (1994). Evolution of mutation rate and virulence among human retroviruses.
    11. (2004). HIV evolution: CTL escape mutation and reversion after transmission.
    12. (2007). HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads.
    13. (1997). Is the clinical course of HIV-1 changing? Cohort study.
    14. (2000). Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men.
    15. (1995). Phenotypic and functional parameters of cellular immunity in a chimpanzee with a naturally acquired simian immunodeficiency virus infection.
    16. (2007). Phillips A
    17. (1990). Prevalence of natural infection with simian immunodeficiency virus and simian T-cell leukemia virus type I in a breeding colony of sooty mangabey monkeys.
    18. (2001). Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai,
    19. (1990). Quality control in the flow cytometric measurement of T-lymphocyte subsets: the multicenter AIDS cohort study experience.
    20. (1995). Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion.
    21. (1995). Recent infection with human immunodeficiency virus and possible rapid loss of CD4 T lymphocytes.
    22. (1998). Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro.
    23. (2005). Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time.
    24. (2004). Selection, transmission, and reversion of an antigen-processing cytotoxic Tlymphocyte escape mutation in human immunodeficiency virus type 1 infection.
    25. (2006). Stable virulence levels in the HIV epidemic of Switzerland over two decades.
    26. (2007). Survey of the temporal changes in HIV-1 replicative fitness in the Amsterdam Cohort.
    27. (1996). Temporal trends of initial CD4 cells counts following human immunodeficiency virus seroconversion in Italy,
    28. (1996). Temporal trends of the natural history of HIV-1 infection following seroconversion between
    29. (1987). The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.
    30. (2000). Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active anti-retroviral therapy: a collaborative reanalysis.
    31. (2000). Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.